Vicore Pharma Holding AB

NASDAQ:VCRE

Medical - Pharmaceuticals

Healthcare
$9.90 -1.66%

-$0.24 today

Market cap
$279.65M
Beta
0.15

Volume 0.00M

Average 0.26M

VCRE Tax Assets

Deferred tax assets that can reduce taxes payable in future periods.

Vicore Pharma Holding ABNASDAQ: VCRE

Tax Assets · Q2 FY2026 · quarter ended Jun 2026

Tax assets of SEK 0 in Q2 FY2026

Q2 FY2026 tax assets was SEK 0.

Context

  • Tax assets amounted to 0.0% of total assets at the end of Q2 FY2026.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterJun 2026
SEK 0— QoQ
Last fiscal yearDec 2025
SEK 0— YoY
Tax Assets past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Tax Assets history

SEK · from the balance sheet

Latest · FY2025
0 SEK
Year-over-year change
—

Tax Assets vs competitors

How VCRE compares with its peers on the latest reported figures

  • Peers report in different currencies, so tax assets is compared through growth and share of total assets rather than absolute size.
  • Tax assets amounts to 0.0% of total assets for VCRE, versus a peer median of 0.2%.
VCRE Competitors
Tax Assets for VCRE and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
LQDALiquidia CorporationJun 2026$914K USD——0.2%
VCREVicore Pharma Holding ABJun 2026SEK 0 SEK——0.0%
AVLNAvalyn Pharma Inc. Common Stock—— ———
Peer median (excluding VCRE) ———0.2%

Competitors are the stored peer set for VCRE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Vicore Pharma Holding AB

NASDAQ:VCRE

Intrinsic Alpha fair value

Locked

Current Price

$9.90

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.